Amanda Gordon
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in
- Oncology 9
- CAR-T cell therapy research 4
- Cancer Treatment and Pharmacology 2
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Gordon C. Jayson (2 shared papers)Hani Gabra (2 shared papers)David E. Parkin (2 shared papers)R. Atkinson (1 shared paper)J. P. Paul (1 shared paper)Robert L. Coleman (1 shared paper)P. Vasey (1 shared paper)A. Hay (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (3 papers)JNCI Journal of the National Cancer Institute (2 papers)Cancer (1 paper)Journal of Pediatric Hematology/Oncology (1 paper)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Amanda Gordon
15 papers receiving 779 citations
Peers
Comparison fields: 5 of 61
- Reproductive Medicine 400
- Obstetrics and Gynecology 137
- Oncology 314
- Genetics 105
- Pathology and Forensic Medicine 116
Countries citing papers authored by Amanda Gordon
This map shows the geographic impact of Amanda Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Gordon more than expected).
Fields of papers citing papers by Amanda Gordon
This network shows the impact of papers produced by Amanda Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Gordon. The network helps show where Amanda Gordon may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 446 | |
| 2 | 2005 | 155 | |
| 3 | On behalf of the Scottish Gynaecological Cancer Trials Group. Phase III Randomized Trial of Docetaxel?Carboplatin Versus Paclitaxel?Carboplatin as First-line Chemotherapy for Ovarian Carcinoma | 2004 | 100 |
| 4 | 2013 | 36 | |
| 5 | Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma. | 1997 | 24 |
| 6 | 2020 | 12 | |
| 7 | 2010 | 9 | |
| 8 | 2023 | 6 | |
| 9 | 2007 | 5 | |
| 10 | 2009 | 2 | |
| 11 | 2011 | 2 | |
| 12 | 2011 | 1 | |
| 13 | 2010 | 1 | |
| 14 | 2011 | 1 | |
| 15 | 2013 | 1 |
About Amanda Gordon
Amanda Gordon is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Neurology and Reproductive Medicine, having authored 15 papers that have together received 801 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), CAR-T cell therapy research (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Multiple Myeloma Research and Treatments (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Cancer Treatment and Pharmacology (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Reproductive Medicine (400 citations), Obstetrics and Gynecology (137 citations), Oncology (314 citations), Genetics (105 citations) and Pathology and Forensic Medicine (116 citations). Amanda Gordon has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Gordon C. Jayson, Hani Gabra, David E. Parkin, R. Atkinson, J. P. Paul, Robert L. Coleman, P. Vasey, A. Hay, Stuart Kaye and Judah Folkman. Their work appears in journals such as Blood, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Cancer and Journal of Pediatric Hematology/Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.